Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Pain × Patient Reported Outcome Measures × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Radiation Injuries 2 Cognitive Dysfunction 2 Brain Neoplasms 2 Thoracic Neoplasms 1 Substance-Related Disorders 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pain 1 Neoplasms, Second Primary 1 Neoplasms, Plasma Cell 1 Neoplasms by Site 1 Multiple Myeloma 1 Lung Neoplasms 1 Lung Diseases 1 Hyperthermia 1 Financial Stress 1 Congenital Abnormalities 1 Carcinoma, Bronchogenic 1 Carcinoma, Basal Cell 1 COVID-19 1 Bronchial Neoplasms 1 Breast Neoplasm Female 1

Interventions

Surveys and Questionnaires 8 Psychiatric Rehabilitation 5 Interviews as Topic 3 Fentanyl 3 Therapeutics 2 Analgesics, Opioid 2 ziprasidone 1 radium Ra 223 dichloride 1 pegfilgrastim 1 exemestane 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Urinary Catheterization 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sevelamer 1 Ropivacaine 1 Rocuronium 1 Restraint, Physical 1 Rehabilitation 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Quality of Life 1 Plastic Surgery Procedures 1 Piperacillin, Tazobactam Drug Combination 1 Physical Therapy Modalities 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05684939 2023-06-13

CAPS

University Hospital, Clermont-Ferrand

Neoplasms, Pain, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡